GVB Biopharma Acquisition

22ND CENTURY ACQUIRES GVB BIOPHARMA GVB Biopharma (“GVB") is a global leader in the manufacturing of hemp-derived active ingredients and finished products servicing the nutraceutical, consumer products and pharmaceutical industries. The acquisition of GVB provides 22nd Century a foundational platform through which it can express and monetize its deep intellectual property portfolio in hemp/cannabis. Ÿ: 22ND CENTURY GROUP (GVB) BIOPHARMA™ 22ND CENTURY GROUP

View entire presentation